Clinical Trial Update: Safety and Efficacy of Cabazitaxel in Pediatric Patients With Refractory Solid Tumors Including Central Nervous System Tumors [Phase 1, Phase 2]

View source ↗

Summary

This trial update evaluates the safety and preliminary efficacy of cabazitaxel in pediatric patients with refractory solid tumors, including central nervous sys…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Tumor
• Malignant Solid Tumor

Drugs mentioned

• Jevtana (cabazitaxel)

Snippet

Sponsor: Sanofi | Conditions: Malignant Solid Tumor - Malignant Nervous System Neoplasm | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2016-08-12